Merck seeks FDA authorization for COVID19 treatment pill
Capsules of the experimental anti-Covid drug molnupiravir, for which Merck is seeking emergency use authorization in the USWASHINGTON - US pharmaceutical giant Merck said Monday that it has applied for emergency use authorization of its oral anti-Covid drug in the United States, a major step towards finding a simple pill to treat the disease.
"The extraordinary impact of this pandemic demands that we move with unprecedented urgency," Robert Davis, chief executive officer and president of Merck, said in the statement."That is what our teams have done by submitting this application for molnupiravir to the FDA within 10 days of receiving the data," he added.
All the patients had lab-confirmed Covid-19 with symptoms that developed within five days of them being assigned to their respective groups.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Invicta spends more than R500m to acquire Dartcom amid fibre raceMove comes as companies seek to gain from explosion in demand for fast home internet thanks to Covid-19
Read more »
Invicta spends more than R500m to acquire Dartcom amid fibre raceMove comes as companies seek to gain from explosion in demand for fast home internet thanks to Covid-19
Read more »
Covid-19 survivors at risk of lingering heart damage, study findsResearchers say the chances of a major cardiovascular event in the first year increases with the severity of the initial illness
Read more »
Cricket SA posts R221m loss as Covid-19 hits incomeThe organisation is pleased with how it has reduced expenditure as revenue plummets from R1bn to R512m
Read more »
Covid-19 infections decrease as SA reports 648 new cases and 25 deathsSouth Africa reported 648 new Covid-19 cases and 25 deaths, the National Institute for Communicable Diseases said in a statement.
Read more »
COVID-19 | WATCH | How does the vaccine certificate work?The Health Department has launched its COVID19 vaccine certificate portal. eNCA anchor Dan Moyane shows you how it works.
Read more »